Sarepta Therapeutics (SRPT) slips 3.79% premarket on the heels of a pre-holiday announcement...

|About: Sarepta Therapeutics, Inc. (SRPT)|By:, SA News Editor

Sarepta Therapeutics (SRPT) slips 3.79% premarket on the heels of a pre-holiday announcement regarding an at-the-market equity offering agreement with Further Lane Securities under which the company may sell shares worth up to $125M in order to fund general corporate purposes including activities related to eteplirsen.